Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Boehringer Ingelheim
Express Scripts
McKesson
Merck

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

HERCEPTIN Drug Profile

See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for HERCEPTIN

Identify potential brand extensions & biosimilar entrants

SponsorPhase
West China HospitalPhase 1/Phase 2
Jiangsu HengRui Medicine Co., Ltd.Phase 1/Phase 2
Veana Therapeutics, Inc.Phase 1

See all HERCEPTIN clinical trials

Recent Litigation for HERCEPTIN

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
CELGENE CORPORATION v. DR. REDDY'S LABORATORIES, LTD.2019-07-12
Genentech, Inc. v. Pfizer Inc.2019-04-05
Genentech, Inc. v. Immunex Rhode Island Corp.2019-03-29

See all HERCEPTIN litigation

PTAB Litigation
PetitionerDate
Forty Seven, Inc.2018-01-08
Pfizer, Inc.2017-06-30
Celltrion, Inc.2017-02-21

See all HERCEPTIN litigation

Pharmacology for HERCEPTIN
Mechanism of ActionHER2/Neu/cerbB2 Antagonists

Patent Text Search: US Patents for HERCEPTIN

These patents were identified by searching patent claims

Supplementary Protection Certificates for HERCEPTIN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
5/2015 Austria   Start Trial PRODUCT NAME: POMALIDOMID UND SEINE PHARMAZEUTISCH AKZEPTABLEN SALZE, SOLVATE, HYDRATE ODER STEREOISOMERE; REGISTRATION NO/DATE: EU/1/13/850 20130805
300822 Netherlands   Start Trial PRODUCT NAME: RITUXIMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/98/067/003 - UITVOERINGSBESLUIT C(2014)2048 20140326
PA2016034 Lithuania   Start Trial PRODUCT NAME: IBRUTINIBAS ARBA FARMACISKAI PRIIMTINA JO DRUSKA; REGISTRATION NO/DATE: EU/1/14/945 C(2016)3293 20160526
300868 Netherlands   Start Trial PRODUCT NAME: IBRUTINIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/14/945 - C(2015)4704 20150707
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Dow
Baxter
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.